BSEGeneral8 Sept 2026 · 8 Sept 2026, 07:16 pm
Reg. 34 (1) of Annual Report for the financial year 2025-2026
Kabra Drugs Ltd · 524322
✦ AI SummaryResults
Kabra Drugs Ltd, now known as Aanjaay Industries Ltd, has submitted its annual report for the financial year 2025-2026, along with a notice for its 37th Annual General Meeting on September 30, 2026. The report includes changes in the board of directors and key managerial personnel, as well as the appointment of a new non-executive independent director and secretarial auditor.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kabra Drugs Ltd - 524322 - Reg. 34 (1) Annual Report.
Attachments (1)
📄pdf
Download →
2a8f8163-f755-4972-8879-f90803c7c00b.pdf
View document text
Date: 08th September 2026
BSE Limited,
Phiroz Jeejeebhoy Towers,
21st Floor, Dalal Street,
Mumbai-400001.
BSE Scrip Code: 524322
Subject: Submission of Annual Report for the financial year 2025-2026.
With reference to the captioned subject and pursuant to Reg 34 of the SEBI (Listing and
Disclosure Requirements) Regulations, we are submitting herewith Annual Report of 37th
Annual General Meeting of the Company to be held on 30th September 2026, Wednesday at
9.00 AM at Fairfield by Marriott Hotel, 169 Rajiv Gandhi Salai, Old, Mahabalipuram Road,
Semmancheri, Chennai-600119.
The Annual Report of the Company has been sent to the shareholders and is enclosed
herewith.
Kindly take the above intimation on your records.
Thanking you,
Yours sincerely,
For Aanjaay Industries Limited
(Formerly known as Kabra Drugs Limited)
Nanjappan Aravind
Managing Director
DIN: 01895602
AANJAAY INDUSTRIES LIMITED
(FORMERLY KNOWN AS KABRA DRUGS LIMITED)
37th ANNUAL REPORT
2025-2026
AANJAAY INDUSTRIES LIMITED (FORMERLY KNOWN AS
KABRA DRUGS LIMITED)
BOARD OF DIRECTORS & KEY MANAGERIAL PERSONNEL
SL. NO NAME OF THE DIRECTOR DESIGNATION
1 Mr. Nanjappan Aravind Managing Director
2 Mr. K N Anand Executive Director
3 Mrs. Anand Anitha Independent Director
(Resigned w.e.f 12th August 2026)
4 Mr. Bangalore Venkatakrishnappa Executive Director
Ananth Kumar (Resigned w.e.f 08th October 2025)
5 Mrs. Ananthkumar Shilpa Independent Director
(Resigned w.e.f 08th October 2025)
6 Ms. Ritu Tiwari Independent Director
(Appointed w.e.f 08th October 2025)
7 Ms. Nikita Sinha Independent Director
(Appointed w.e.f 08th October 2025)
8 Ms. Monam Kapoor Independent Director
(Appointed w.e.f 21st April 2026)
SL. NO KEY MANAGERIAL PERSONNEL DESIGNATION
1 Mr. Pavanasam Chief Financial Officer
(Appointed w.e.f 08th October 2025)
2 Mr. Bangalore Venkatakrishnappa Chief Financial Officer
Ananth Kumar (Resigned w.e.f 08th October 2025)
3 Ms. Monika Nishant Gattani Company Secretary
COMPANY INFORMATION
CIN L21002TN1989PLC197216
Registered Office Address No:3, 2nd Floor, Swaminathan Street, West
Mambalam, Chennai – 600033
Bankers Name South Indian Bank
M/s. PPN and Company Chartered
Statutory Auditor
Accountants
Secretarial Auditor Mrs. Twinkle Agarwal, Practicing Company
Secretary
Internal Auditor M/s. Karthik L & Associates, Chartered
Accountants
Registrar & Transfer Agent M/s Skyline Financial Services Pvt.Ltd
A/505, Dattani Plaza, Andheri-Kurla Road,
Safeed Pool, Andheri (East), Mumbai-400072
Email id aanjaayindustries@gmail.com
Website www.aanjaayind.com
N O T I C E
Notice is hereby given that the 37th Annual General Meeting of the Members of AANJAAY INDUSTRIES LIMITED
(FORMERLY KNOWN AS KABRA DRUGS LIMITED) will be held on 30th September 2026, Wednesday at 09:00 A.M at
Fairfield by Marriott Hotel, 169 Rajiv Gandhi Salai, Old, Mahabalipuram Road, Semmancheri, Chennai-600119 to
transact the following business: -
ORDINARY BUSINESS:
1. To receive, consider and adopt the Audited Financial Statement of the Company for the financial year ended 31st
March 2026, and the reports of the Board of Directors and Auditors thereon.
2. To appoint a director in place of Mr. Kuniamuthur Nanjappan Anand (DIN: 03230186) who retires by rotation, and
being eligible, offers himself for re-appointment.
SPECIAL BUSINESS:
3. TO APPOINT MS. MOONAM KAPOOR (DIN: 09278005), AS NON EXECUTIVE INDEPENDENT DIRECTOR:
To consider and if thought fit, to pass with or without modification(s), the following resolution as Ordinary Resolution:
"RESOLVED THAT pursuant to the provisions of Section 149, and 152 read with Schedule IV and other applicable
provisions, if any, of the Companies Act, 2013 read with Companies (Appointment and Qualification of Directors)
Rules, 2014 (including any statutory modification(s) or re-enactment thereof, for the time being in force), and
applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from
time to time, pursuant to the recommendation of Nomination and Remuneration Committee and Board at their
meetings held on 02nd September 2026, Ms. Moonam Kapoor (DIN: 09278005) who was appointed as Additional Non-
Executive Independent Director of the Company w.e.f. 21st April 2026, who has submitted a declaration that she meets
the criteria of independence under Section 149(6) of the Companies Act, 2013 and who is eligible for appointment
under the provisions of the Companies Act, 2013 and rules made thereunder and SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, be and is hereby appointed as an Non-Executive Independent Director
of the Company for the first term of five consecutive years effective from 21st April 2026 till 20th April 2031 and shall
be liable to retire by rotation.
RESOLVED FURTHER THAT Mr. Nanjappan Aravind, Managing Director and Chief Financial Officer & Company
Secretary of the Company be and are severally hereby authorized to file necessary forms with Registrar of Companies
and to do all such act, deeds and things as may be considered necessary to give effect to the above said resolution.”
4. TO APPOINT MRS. TWINKLE AGARWAL AS SECRETARIAL AUDITOR OF THE COMPANY:
To consider and if thought fit, to pass with or without modification(s), the following resolution as Ordinary Resolution:
RESOLVED THAT pursuant to the provisions of Section 204(1) of the Companies Act, 2013, read with Rule 9 of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, Regulation 24A of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions, if any (including any
statutory modifications, amendments, or re-enactments thereof), consent of the Members be and are hereby
accorded for the appointment of Mrs. Twinkle Agarwal, Practicing Company Secretary, as the Secretarial Auditor of
the Company for a period of five financial years commencing from the financial year 2026–2027 to 2030–2031 at such
remuneration, as may be mutually agreed between the Board of Directors of the Company and the Secretarial
Auditors.
RESOLVED FURTHER THAT Mr. Nanjappan Aravind, Managing Director and Chief Financial Officer & Company
Secretary of the Company be and are severally hereby authorized to file necessary forms with Registrar of Companies
and to do all such act, deeds and things as may be considered necessary to give effect to the above said resolution.”
By the order of the Board of Directors
For AANJAAY INDUSTRIES LIMITED
(FORMERLY KNOWN AS KABRA DRUGS LIMITED)
Sd/- Sd/-
NANJAPPAN ARAVIND K N ANAND
MANAGING DIRECTOR DIRECTOR
DIN: 01895602 DIN: 03230186
PLACE: CHENNAI
DATE: 02ND SEPTEMBER 2026
Notes:
1. A member entitled to attend, and vote is also entitled to appoint a proxy to attend and vote instead of
himself/herself and the proxy need not be a member. Proxies in order to be effective must be received by the
company not less than 48 hours before the commencement of this meeting. Members/ proxies should bring their
attendance slip duly filled in order to attend the meeting. A person can act as proxy on behalf of members‟ not
exceeding fifty (50) and holding in the aggregate not more than ten percent of the total share capital of the
company.
2. The Explanatory Statement pursuant to section 102 of the Companies Act, 2013 is annexed hereunder and forms
part of the Notice.
3. In case of joint holders attending the meeting, only such joint holder who is higher in the order of names will be
entitled to vote.
4. The Register of Members and Share Transfer Register of the Company will remain close from Thursday, 24th
September 2026, to Wednesday, 30th September 2026 (both days inclusive).
5. Shareholders desiring any information as regards the accounts are requested to write to the Company at least 10
Days before the Annual General Meeting to enable the Management to keep the information ready.
6. The shareholders are hereby informed that all the correspondence in connection with the shares
[Showing first 8,000 characters — download PDF for full document]